Aktis Oncology Pursues $200 Million IPO On Promising Early Stage Studies
Subscribe to Updates
Get the latest tech, social media, politics, business, sports and many more news directly to your inbox.

Aktis Oncology Pursues $200 Million IPO On Promising Early Stage Studies